 The globalization strategy of Biocia is focused on working closely and effectively with leading “local” companies which are active in their therapeutic and/or surgical segments of ophthalmic and otolaryngology markets. Our objective of optimizing our Products and Services according to the domestic and/or international needs and laws of specific markets is implemented on a country-by-country basis.
We invite small, mid-sized and/or larger leading companies focused in ophthalmology and/or otolaryngology to contact us for information about our technology, products and licensing opportunities with Biocia.
Biocia is a North American-based Company with offices located in New Jersey, USA and Quebec, Canada. Within the Biocia organization, there are two separate business units including Biocia Inc. and the Biocia Consulting Group, as a Division of Biocia Inc. Both Biocia business units have a synergistic effect upon each other relating to the advancement of Biocia businesses and the support of our licensing partners, agents, customers and stakeholders. The group is focused on product formulation, development, research, clinical testing, registration, commercialization, reimbursement, and licensing of Biocia technology and the proprietary technology of our partners for specific global markets.
|
